As representatives of hundreds of thousands of scientists across the country, we write to urge you to adhere to stringent scientific and medical standards as the Food and Drug Administration (FDA) prepares to assess the safety and efficacy of vaccine candidates that are currently in phase III clinical trials.

As leaders of the nation's scientific societies, we stand ready to work with the National Science Foundation to address and surmount the challenges that COVID-19 poses to the research enterprise. We urge your continued support for the valuable programming we provide and encourage you to foster a culture of innovation in order to meet the short- and long-term needs of the scientific community

At this time of great challenges for our nation, we write to thank you for your leadership in confronting inequities in the U.S. scientific enterprise that have prevented full participation of racial and ethnic groups underrepresented in STEM.

On behalf of the scientific, medical, and patient communities dedicated to advancing human health, we write to express ongoing concerns about the NIH Human Fetal Tissue Ethics Advisory Board and its final report that would block funding for all but one research proposal seeking to use human fetal tissue.

On behalf of the scientific, medical, and patient communities dedicated to advancing human health, we write to express our collective, strong support for the continued use of human fetal tissue in life-saving biomedical research.

The biological sciences research and education community is deeply concerned by the July 6, 2020, guidance from United States Immigration and Customs Enforcement (ICE) that would force international students to leave the country if they do not participate in in-person instruction during the fall 2020 semester.

AIBS stands with all people and organizations working to end racism and injustice through peaceful protest, legal action, policy change, and systemic reform.

We, the undersigned scientific organizations representing tens of thousands of members of the American biomedical research enterprise, are alarmed by the National Institutes of Health's revocation of a peer-reviewed research grant for studies of coronaviruses by EcoHealth Alliance. Not only is this decision counterintuitive, given the urgent need to better understand the virus that causes COVID-19 and identify drugs that will save lives, but it politicizes science at a time when, if we are to stamp out this scourge, we need the public to trust experts and to take collective action.

More than ever before, the country is relying on the scientific enterprise to help guide our path to recovery. Scientific progress and U.S. economic development are vastly accelerated by bringing the best and brightest minds together. Therefore, we urge you to prioritize the immigration of science and technology talent that will spur the scientific breakthroughs and economic growth of the United States that is needed for rapid recovery from the COVID-19 pandemic.

Our organizations strongly oppose EPA’s supplemental notice of proposed rulemaking (SNPRM) to the “Strengthening Transparency in Regulatory Science” proposed rulemaking. Like the original proposed rule, this supplemental proposal would undermine sound science and put Americans’ health and the environment at risk. We are deeply concerned with EPA’s continued efforts to impede the use of critical science and implore the agency to withdraw the proposal.